Amlong-H

Quick links to important sections

Amlong-H

Method of action: Antihypertensive

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlong-H

Quick Facts

Property Description
Active ingredients Amlodipine, Hydrochlorothiazide
Form Tablet (Fixed-Dose Combination)
Pharmacological class Antihypertensive Drug (CCB + Diuretic)
General purpose Management of high blood pressure
Origin Synthetic

Defining Amlong-H: Identity, Form, and Classification

Amlong-H is a synthetic Prescription-only medicine, recognized within the pharmaceutical domain as a Fixed-Dose Combination (FDC) Antihypertensive Drug. The product identity is defined by its presentation as a tablet intended for oral administration, a preparation method typical of long-term treatments for high blood pressure. Amlodipine is widely used to treat high blood pressure, establishing it as a foundation of this combination therapy. Amlong-H offers a distinct delivery method by combining two separate agents into one unit, a characteristic recognized for potentially improving treatment adherence compared to administering two separate pills.

The Dual Composition and Pharmacological Class

Its efficacy is grounded in two specific Active ingredients: Amlodipine and Hydrochlorothiazide. Amlodipine is characterized as a dihydropyridine Calcium Channel Blocker (CCB), functioning primarily to promote Vasodilation. The second ingredient, Hydrochlorothiazide, is classified as a Thiazide Diuretic, whose role is to encourage the kidneys to excrete excess salt and water, thereby supporting Volume depletion. The combination of agents with different mechanisms, like a CCB and a Diuretic, is intended to improve the management of elevated blood pressure. This dual approach is recognized as an effective method for pressure control.

General Purpose of the Combination Antihypertensive Drug

The core, high-level purpose of Amlong-H is to achieve an efficient and sustained reduction in Hypertension. This combination product leverages the synergistic effect of arterial relaxation and fluid management to reduce the pressure exerted on arterial walls, a key objective of Antihypertensive therapy. By addressing both vascular resistance and circulating fluid volume, the drug is typically used as a convenient option when monotherapy with either a CCB or a diuretic alone proves insufficient.

What side effects are possible with Amlong-H?

Possible Side Effects and Safety Information

The safety profile for Amlong-H, a fixed-dose combination of Amlodipine and Hydrochlorothiazide, is based on the documented adverse reactions and official safety classifications from regulatory authorities. Adverse reactions are formally grouped by the system-organ class affected and their observed frequency in clinical trials.

Frequency-Classified Adverse Reactions

The most frequently documented side effects (classified as ge 2% incidence in clinical trials) include dizziness, headache, peripheral edema (swelling), fatigue, muscle spasms, back pain, and nausea. Effects are also noted across various systems, including the Gastrointestinal (e.g., dyspepsia) and Metabolic systems, the latter encompassing documented changes like Hypokalemia and Hyperglycemia.

Serious Adverse Reactions and Restrictions

Official labeling documents specific serious adverse reactions. These include the risk of Fetal Toxicity if used during pregnancy, Severe Hypotension, and the potential for increased Angina or Myocardial Infarction upon initiating or increasing the dose of the Amlodipine component. The Hydrochlorothiazide component is also associated with rare but critical conditions such as Acute Myopia (nearsightedness), Secondary Angle-Closure Glaucoma, and Acute Respiratory Distress Syndrome (ARDS).

Population and Context-Specific Safety Notes

The medicine is subject to specific constraints based on certain conditions and patient groups. It is contraindicated in clinical states such as Anuria, Severe Hypotension, and Shock. Use is not recommended in patients with severe hepatic impairment or severe renal impairment (creatinine clearance <30 mL/min). Furthermore, certain risks, such as the ocular effects and the risk of worsening angina, are officially documented as being more likely to appear within the hours to weeks of drug initiation.

Overdose and Emergency Response

The official regulatory profile for Amlong-H overdose documents risks associated with both active components. Overexposure to Amlodipine primarily leads to profound and prolonged systemic hypotension (low blood pressure) due to excessive peripheral vasodilation, which may be accompanied by reflex tachycardia or bradycardia. The most severe complication documented for this effect is progression to refractory shock.

Overdose of the Hydrochlorothiazide component results in severe fluid and electrolyte imbalance, including hypokalemia and life-threatening hyponatremia. Manifestations of these imbalances include dehydration, drowsiness, and muscle cramps, with documented potential for severe neurological events such as seizures.

Regulatory documents mandate that any suspected overdose requires immediate medical attention. Patients must contact emergency services or a Poison Control Center immediately, especially if symptoms involve fainting, collapse, or prolonged low blood pressure. Management is defined as supportive, focused on correcting hypotension and critical electrolyte deficits. Due to the long plasma half-life of Amlodipine, prolonged hospital observation with continuous cardiac and laboratory monitoring is required.

Therapeutic Uses of Amlong-H

Managing Symptoms Related to Uncontrolled High Blood Pressure

Amlong-H is relevant in contexts involving heightened systemic burden, and may be applied when initial symptomatic management is insufficient. The medication helps to manage high blood pressure, and is applied in addressing conditions where symptoms create noticeable physiological strain. It is used in situations involving certain distressing symptoms to support the goal of stable blood pressure management.


Supportive Therapy for Systemic Imbalance

This therapy is relevant for managing symptoms related to systemic imbalance, specifically managing symptoms related to persistent high pressure and systemic fluid imbalance. The combination may assist with supporting functional stability and is relevant for managing symptom clusters that may become intense or disruptive. This approach generally contributes to improved day-to-day comfort during periods where symptoms may interfere with routine activities.

“The combination assists with maintaining functional stability by addressing symptom clusters that may become intense or disruptive.”

The medication is commonly used across conditions presenting with heightened symptoms, such as primary hypertension, and is relevant for easing symptoms related to persistent pressure and systemic fluid imbalance.

Quick Fact: Relief for Persistent Pressure Description
Therapeutic Goal Sustained management of high arterial pressure.
Symptom Focus Systemic imbalance and noticeable physiological strain.
Clinical Context Management when initial symptomatic assistance is needed.
Primary Benefit Helps ease the overall systemic burden.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Amlong-H is indicated for use in the adult population when single-component therapy with Amlodipine or Hydrochlorothiazide alone has proven insufficient for blood pressure management. Official regulatory documents define clear population restrictions and absolute prohibitions for its use.

Contraindications and Prohibited Use

Use is strictly prohibited for populations with a known hypersensitivity to Amlodipine, Hydrochlorothiazide, dihydropyridine derivatives, or any sulfonamide-derived drugs. The medicine is also officially contraindicated in patients with Anuria, severe hepatic impairment, or severe renal impairment (Creatinine clearance le 30 mL/ min). Specific conditions, such as refractory hypokalaemia, also define non-eligibility.

Population-Specific Limitations

  • Age-Based Use: The medicine is not recommended for the pediatric population (under 18 years) because its safety and effectiveness have not been established. While adults are the approved group, older adult patients may exhibit greater sensitivity.
  • Reproductive Health: Use is to be avoided during pregnancy and breastfeeding, with regulatory instruction to discontinue therapy immediately upon the detection of pregnancy.
  • Conditional Use: Conditions like volume or salt depletion must be corrected prior to initiation of therapy, and special caution is indicated for patients with conditions like aortic stenosis.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Amlong-H (Amlodipine and Hydrochlorothiazide) is based on the documented effects of its two active ingredients and focuses strictly on official regulatory constraints.

Pharmacokinetic and Exposure-Altering Interactions

The co-administration of CYP3A4 inhibitors (e.g., certain antifungals or antivirals) is officially stated to increase the systemic exposure of the Amlodipine component. Conversely, CYP3A4 inducers (e.g., Rifampicin) may decrease plasma concentrations of Amlodipine. For combination with Simvastatin, regulatory labeling restricts the Simvastatin daily dose to 20 mg due to increased systemic exposure. The diuretic component increases the risk of lithium toxicity by reducing its clearance, necessitating monitoring.

Pharmacodynamic and Administration Constraints

Certain combinations are formally contraindicated: use is prohibited in patients with Anuria. The combination with Aliskiren is contraindicated under conditions of diabetes or renal impairment (GFR < 60 mL/min). Interactions with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are documented to potentially reduce the antihypertensive effect and increase the risk of renal impairment. The risk of orthostatic hypotension is potentiated by co-administration with Alcohol, Barbiturates, or Narcotics.

Timing Separation Requirement

Co-administration with Cholestyramine or Colestipol resins requires a mandatory timing separation rule: the Hydrochlorothiazide component must be administered at least 4 hours before or 4 to 6 hours after the resin to maintain its absorption.

Mechanism of Action

Regulation of Calcium-Dependent Vascular Tone (Amlodipine)

The Amlodipine component acts as an antagonist (blocker) of L-type voltage-gated calcium channels (Cav1.2) found on vascular smooth muscle cells. By preventing the required influx of extracellular Ca^2+ ions, this mechanism inhibits the contractile process of the muscle cells, leading to peripheral arteriolar vasodilation (widening of the blood vessels). This ultimately lowers the Total Peripheral Resistance (TPR), which decreases the afterload on the cardiac muscle and reduces the force exerted on arterial walls.

Modification of Renal Electrolyte Transport (Hydrochlorothiazide)

The Hydrochlorothiazide (HCTZ) component acts as an inhibitor of the sodium-chloride cotransporter (NCC) in the distal convoluted tubules of the kidney. Blocking the Na^+/ Cl^- cotransporter prevents their reabsorption, creating an osmotic gradient that results in increased excretion of water (diuresis). The net loss of sodium, chloride, and water leads to a decrease in extracellular fluid volume and plasma volume. This volume reduction decreases the amount of blood returning to the heart (preload), contributing to the overall reduction of pressure exerted on arterial walls.

Dosage and Administration Information

Amlong-H is a Fixed-Dose Combination (FDC) tablet intended for oral administration and is typically used as a follow-on or replacement therapy for chronic high blood pressure, not for the initial treatment of hypertension. The established usage pattern requires the tablet to be taken once daily, preferably at a consistent time, and can be administered with or without food. The tablet should be swallowed whole with water.

Dosing, based on component ranges, starts at lower combination strengths—for example, 5 mg Amlodipine and 12.5 mg Hydrochlorothiazide—and may proceed up to a maximum of 10 mg Amlodipine and 25 mg Hydrochlorothiazide daily. A two-week period is typically observed between any dosage adjustments to ensure the full effect of the previous dose is assessed before titration.

Specific administrative adjustments are required for certain populations. For both older adults and patients with hepatic impairment, a lower initial dose, such as 2.5 mg Amlodipine equivalent, and slow titration is typically utilized due to altered drug clearance. Furthermore, the use of this combination is not recommended in individuals diagnosed with severe renal impairment (creatinine clearance <30 mL/min), which serves as a constraint on the therapy's appropriate usage.

Recent Clinical Evidence

Recent Clinical Evidence

Core Research Focus

Clinical research involving the amlodipine/hydrochlorothiazide combination was developed to target specific physiological pathways implicated in blood pressure regulation. This research focused on investigating the relationship between this approach and the overall control of hypertension.

Clinical Trial Findings: Research Outcomes

Studies have investigated the change in blood pressure (BP) levels among participants who received the combination treatment, as measured by established clinical metrics (systolic and diastolic BP) over defined periods. Research also explored the patterns observed in the reduction of elevated BP and the proportion of participants achieving target BP goals.

Investigating Long-Term Follow-up

The duration of observed BP changes has been one area of study. Some trials followed participants for extended periods to observe the sustainability of the changes noted in BP control.

Safety and Tolerability Profiles

Studies have evaluated the safety profile of the combination. The primary focus was on the incidence of common adverse events related to both components, such as ankle swelling (associated with amlodipine) and electrolyte imbalances (associated with hydrochlorothiazide).

The tolerability profile reported in trials noted that side effects were predominantly described as mild to moderate, with the most commonly reported being headache and dizziness.

Onset of Action Research

Research has examined the timeline for observed changes in BP. Some clinical studies measured the time to the earliest documented alteration in BP readings among trial participants following the start of treatment.

Key Studies & References

  1. Hypertension in adults: diagnosis and management (NICE Guideline NG136)

Frequently Asked Questions (FAQ)

Common questions about Amlong-H (FAQ)


Q: Why do some people say Amlong-H makes them feel dizzy?

A: Dizziness is a commonly reported side effect, noted in 2% or more of patients in clinical trials. This feeling may be related to the drug effectively lowering blood pressure, which can sometimes cause a rapid drop, known as orthostatic hypotension. Official safety information indicates that the risk of low blood pressure (orthostatic hypotension) is increased when the medication is used alongside substances like alcohol or narcotics.


Q: Can Amlong-H cause a dry cough?

A: According to the official product information and data from clinical trials, a dry cough is not listed among the frequently reported or common side effects associated with the Amlodipine/Hydrochlorothiazide combination.


Q: Are there any known interactions between Amlong-H and herbal supplements?

A: Official regulatory guidance requires that patients disclose all concomitant use, including any prescription and over-the-counter medicines, vitamins, minerals, and herbal products. This is because some supplements may interact with the drug’s components, which could potentially affect the medication’s efficacy or safety.


Q: What happens if I miss a dose of Amlong-H occasionally?

A: Official patient counseling information addresses how to handle a missed dose, stating that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next regularly scheduled dose, the regulatory instruction is to skip the missed dose and resume the regular schedule. The labeling specifies that a double dose should not be taken to compensate for a missed dose.


Q: Can Amlong-H cause sensitivity to the sun?

A: Yes, the Hydrochlorothiazide component (the diuretic) has been associated with photosensitivity, which is an increased sensitivity to sunlight. Due to this risk, official drug safety communications advise that patients protect their skin from sun exposure.


Q: What is the typical age range of people prescribed Amlong-H?

A: Amlong-H is officially indicated for use in the adult population. The medicine is not recommended for children and adolescents under 18 years of age because its safety and effectiveness have not been established in the pediatric population.


Q: Can Amlong-H affect a person's mood or cause depression?

A: Mood changes, including depression, are not listed among the common side effects or serious adverse reactions documented in the official prescribing information for the drug combination.


Q: Are the ingredients in Amlong-H used to treat anything else?

A: Yes, the two active ingredients have other indications. Amlodipine is individually approved to treat high blood pressure and coronary artery disease/angina (chest pain). Hydrochlorothiazide is approved for high blood pressure and also for treating edema (fluid retention).


Q: What clinical trials support the use of Amlong-H for hypertension?

A: The use of Amlong-H is supported by clinical studies that demonstrated the combination to be more effective at reducing blood pressure than using either Amlodipine or Hydrochlorothiazide alone. These study findings, which measure the change in blood pressure and the rate of achieving target goals, form the basis of the drug's regulatory approval.


Q: Does Amlong-H help protect against heart attack or stroke?

A: The general goal of managing high blood pressure is to reduce the risk of serious cardiovascular events, such as strokes and myocardial infarctions (heart attacks). The drug is indicated for lowering high blood pressure, which is linked to this overall reduction in risk.


Q: Does Amlong-H cause weight gain or loss?

A: Significant changes in body weight (either gain or loss) are not listed as common or frequently reported side effects in the official prescribing information or data from clinical trials.


Q: How does the body eliminate Amlong-H after it has worked?

A: The two components are eliminated differently. Amlodipine is largely processed by the liver into inactive metabolites, which are primarily passed out of the body in the urine. The diuretic component, Hydrochlorothiazide, is mainly eliminated unchanged by the kidneys.


Q: Are there any specific vitamins that interact negatively with Amlong-H?

A: Official regulatory guidance requires disclosure of all vitamins, minerals, and other supplements that are being taken. This caution is applied broadly because some supplements may interact with the drug's active ingredients, potentially altering how the medication works.


Q: Why do some forums discuss a risk of gout with Amlong-H?

A: The Hydrochlorothiazide component is a thiazide diuretic that is documented to potentially cause hyperuricemia (an increase in uric acid levels in the blood). Since gout is caused by the buildup of uric acid, this metabolic change is listed as a potential risk factor in the official warnings and precautions section.


Q: Does Amlong-H have any effect on cholesterol levels?

A: Official drug information indicates that the Hydrochlorothiazide component is associated with potential metabolic changes, including the possibility of slight increases in cholesterol and triglyceride levels.


Q: Can people with asthma safely take Amlong-H?

A: Official drug information notes that caution is required for patients with a history of allergies or bronchial asthma. Furthermore, the diuretic component is a sulfonamide-derived drug and is strictly contraindicated (prohibited) for anyone with a known hypersensitivity to that class of medications.


Q: Is Amlong-H prescribed for types of high blood pressure other than essential hypertension?

A: The medicine is indicated for the treatment of hypertension (high blood pressure). The regulatory label defines its purpose as general hypertension treatment and does not specify that it must only be used for essential hypertension.


Q: Why is it important to keep taking Amlong-H even if I feel fine?

A: Official patient information indicates that stopping treatment may lead to a recurrence of high blood pressure. Since hypertension often has no noticeable symptoms, continued therapy is necessary to sustain the reduction in the risk of serious events like stroke or heart attack.


Q: What is the effect of Amlong-H on eye pressure?

A: The diuretic component (Hydrochlorothiazide) carries a risk of causing a sudden reaction that results in acute transient myopia (sudden nearsightedness) and acute angle-closure glaucoma. These symptoms, which include eye pain or decreased vision, typically appear within hours to weeks after starting the treatment.


Q: Is it possible for Amlong-H to cause problems with sleeping?

A: Insomnia (difficulty sleeping) is not listed as a common side effect in the official drug information. However, other documented side effects, such as dizziness and fatigue, could potentially affect a person's sleep patterns.

How should Amlong-H be stored and disposed of?

The storage and disposal of Amlong-H (amlodipine and hydrochlorothiazide) must strictly adhere to the conditions mandated by regulatory labeling to maintain the tablets' integrity.

Storage Requirements

The medicine must be stored at a temperature not exceeding 30 C. The tablets require protection from both light and moisture and must be kept in a tightly closed container.

Child Safety and Disposal

Official regulations require the medicine to be stored out of the reach of children. Regarding disposal, outdated medicine should not be kept. Instead, patients must ask a healthcare professional for guidance on the proper method for discarding any unused or expired product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlong-H found in:

A-Z Index: